Medical Metrics

What Medical Metrics does

Medical Metrics, Inc. (MMI) is a Houston-based, privately held imaging core lab and Contract Research Organization (CRO) founded in 2000 by Dr. John A. Hipp. The company provides independent, full-service image analysis and scientific consulting for global multi-center clinical trials spanning preclinical through post-market surveillance, serving pharmaceutical and biotechnology companies, medical device manufacturers, and CROs across therapeutic areas including spine, orthopedics, cardiovascular, neurology, ENT, gastrointestinal/urology, and oncology.

The firm's technology core is QMA® (Quantitative Motion Analysis), a proprietary, FDA 510(k)-cleared semi-automated software algorithm for radiographic measurement and image registration, validated in over 200 peer-reviewed publications and proven at least 4x more accurate than conventional techniques (within 0.5 degrees and 0.5 mm). The newer SpineCAMP™ platform extends this with AI-powered image analysis for spine health assessment, also FDA 510(k)-cleared (October 2023). Service offerings cover the full clinical trial imaging lifecycle: imaging endpoint strategy design, image review charter development, clinical site management, expert image reads by board-certified physicians, data management with FDA 21 CFR Part 11 compliant infrastructure, image quality and compliance monitoring, and publication strategy. Operations are ISO 9001:2015 certified.

MMI operates a direct enterprise sales model with quote-based pricing targeting sponsor-side clinical teams. Revenue is derived from B2B professional services contracts and, increasingly, from software-enabled workflows. The company maintains global reach via partnerships (e.g., Micron, Inc. for international coverage and oncology; Healthcare Inroads, LLC for cardiovascular trials) and reports contributing to more than 50 pivotal regulatory approvals across U.S. and international pathways across 300+ studies since inception.

Name

Medical Metrics

Legal name

Medical Metrics, Inc.

Website

https://medicalmetrics.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Medical Metrics is a Houston-based imaging core lab and CRO providing independent, FDA-cleared image analysis and full-service clinical trial imaging support to pharmaceutical, biotechnology, medical device, and CRO sponsors across multiple therapeutic areas.

Ownership category

akta.pro rank

Product category

Clinical Trial Imaging Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM), Medical Imaging AI (HDAAAEAH), SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)

Keywords

• Imaging core lab services
• Clinical trial imaging
• Medical image analysis
• Radiographic measurement software
• Contract research organization

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Imaging Core Lab Services: Full-service imaging core lab services for clinical trials including imaging endpoint strategy design, expert image analysis, data interpretation, and publication strategy. Services are provided to pharmaceutical, biotech, and medical device companies conducting global clinical trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Medical Metrics, Inc. (MMI) operates as an independent imaging core lab providing full-service clinical trial imaging solutions to pharmaceutical, biotechnology, medical device, and CRO clients. Services span the complete trial lifecycle from preclinical consultation and imaging endpoint strategy through expert image analysis, data management, image quality monitoring, and publication support, underpinned by proprietary FDA 510(k)-cleared technologies including QMA® (Quantitative Motion Analysis) and the AI-powered SpineCAMP™ platform.

Product overview

Medical Metrics, Inc. (MMI) operates as an imaging core lab and Contract Research Organization (CRO) offering a unified platform of clinical trial imaging services. The core technology portfolio includes QMA® (Quantitative Motion Analysis), MMI's proprietary FDA 510(k)-cleared software for radiographic measurement and image enhancement, and SpineCAMP™, an AI-powered image analysis platform for spine health assessment. MMI's service offerings span the complete clinical trial lifecycle from preclinical consultation through post-market surveillance, encompassing expert image analysis, imaging endpoint strategy, site management, data management, and publication support. The company serves multiple therapeutic areas including spine, orthopedics, cardiovascular, ENT, neurology, and oncology.

Differentiator

Problem solved

Functional benefit

Brands

• SpineCAMP™: AI-powered image analysis platform for spine health assessment, including dynamic X-ray analysis and clinical decision support for spinal instability or fusion assessment.
• QMA®

Products and services

• QMA® (Quantitative Motion Analysis) Proprietary semi-automated software algorithm for image registration and quantitative measurements between different X-rays of the same subject, used by sponsors and CROs in musculoskeletal, spine, and orthopedic clinical trials.
• SpineCAMP™ AI-powered clinical decision support software for spine surgeons and clinical trial sponsors that analyzes X-rays to generate enhanced visualizations and reports supporting assessment of spine health, instability, and fusion. FDA 510(k) cleared.
• Expert Image Analysis Independent, centralized image reads performed by board-certified, fellowship-trained, practicing physician reviewers to evaluate product performance in clinical trials across multiple therapeutic areas.
• Imaging Endpoint Strategy & Scientific Consulting Design of study imaging endpoints and research assessment methodologies tailored to the unique needs of clinical trial sponsors.
• Image Review Charter Development Custom imaging protocol design tailored to specific treatment therapies, applying a one-size-does-not-fit-all approach for trial sponsors.
• Clinical Site Management Service that prepares clinical sites to acquire images necessary for high-quality, reliable imaging outcomes in clinical trials.
• Data Management & Quality Assurance Comprehensive data management with quality assurance, including trend tracking and outlier checks on imaging data.
• Data Interpretation & Publication Strategy Summarization of imaging outcomes in concise, easy-to-interpret form to support publication and downstream communication.
• MMI Swift Image Transfer, Storage & Access Secure image transfer, storage, and access platform for clinical trial imaging data.
• Post-Market Surveillance Post-market product surveillance services for approved medical devices.
• Image Quality & Site Compliance Monitoring Digitization and review of all clinical trial images to ensure quality and compliance to imaging protocols.
• Preclinical Services Preclinical consultation and imaging services for early-stage device development.
• Project Management Comprehensive project management for clinical trial imaging operations.

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Healthcare Inroads, LLC (HCIR)coreStrategic or Co-development Partner · 29 October 2025MMI and Healthcare Inroads have deepened their collaboration to support cardiovascular clinical trials. The partnership involves providing expertise in study design, imaging endpoints, and analysis workflows, evaluating advanced vascular technologies, and offering services across major cardiovascular modalities to improve trial quality and efficiency. The collaboration enables expanded impact in cardiovascular clinical trials.
• Micron, Inc.coreStrategic or Co-development Partner · 1 December 2024US-based Medical Metrics, Inc. and Japan-based Micron, Inc. are teaming up to create a global imaging core lab offering for clinical trials. The collaboration supports Oncology trials across the full range of the human body, covering all major cancer imaging modalities and response criteria. This partnership expands MMI's global reach and oncology capabilities.
• OptinosecoreStrategic or Co-development Partner · 13 May 2024MMI partnered with Optinose on their chronic rhinosinusitis (CRS) clinical program for the ReOpen trials. MMI developed validated semi-automated 3D analysis methodology to measure mucosal thickening volumes of the sinuses using thin-slice CT scans. The trials received FDA approval for XHANCE nasal spray, demonstrating the partnership's success in supporting regulatory-approved treatments.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• inviCRO: inviCRO is a specialized imaging core lab for clinical trials, providing quantitative image analysis and biomarker services to pharma and biotech — closely comparable to MMI's model with emphasis on advanced imaging modalities and translational science.
• Ixico plc: Ixico provides AI-enabled imaging analytics and imaging core lab services for clinical trials, particularly in neurology, oncology, and rare disease. It is directly comparable to MMI's AI imaging capabilities (akin to SpineCAMP) and clinical trial focus.
• Calyx (formerly Parexel Imaging): Calyx provides independent medical imaging services and AI-enabled imaging analysis for clinical trials, with FDA 21 CFR Part 11 infrastructure. It directly overlaps MMI's offering across therapeutic areas including oncology, neurology, and musculoskeletal indications.
• VirtualScopics (Philips): VirtualScopics (acquired by Philips) provided imaging core lab and quantitative image analysis for oncology and musculoskeletal clinical trials — historically a direct competitor to MMI's oncology and orthopedics imaging core lab services.
• Clario (formerly BioClinica): Clario is the largest dedicated imaging core lab and eCOA provider for clinical trials, offering the same independent image analysis, regulatory endpoint services, and FDA-cleared workflows that MMI provides — directly competing for pharma, biotech, and medical device sponsor trials.
• ERT (now part of Clario): ERT specialized in clinical trial endpoint technologies including cardiac safety and imaging; now integrated into Clario, it represents the consolidated imaging-and-endpoint competitor model MMI faces as CROs roll up specialized imaging capabilities.

Emerging players

• Perspectum: Perspectum develops AI-driven medical imaging analysis software with applications in clinical trials and clinical practice, particularly in metabolic and hepatic disease. It is comparable to MMI's AI imaging product strategy (e.g., SpineCAMP) though focused on different therapeutic areas.

Broad incumbents

• ICON plc: ICON is a top-5 global CRO with a substantial imaging services division (formed via PRA Health and other acquisitions). It competes with MMI on imaging endpoints for global clinical trials while offering a much broader portfolio that includes data management, biometrics, and central lab.
• Medpace Holdings: Medpace is a mid-sized global CRO that has invested in imaging core lab capabilities alongside its full-service clinical development offering. It competes with MMI for imaging-enabled trial work, particularly in cardiovascular and oncology.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO offering central laboratory, imaging, and clinical development services across multiple therapeutic areas. It competes with MMI's full-service clinical trial imaging model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medical-metrics-inc
• Xx.com/MedicalMetrics

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Metrics